Terminated PHASE4 INTERVENTIONAL NCT00418678

A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting

Sponsor: Bausch Health Americas, Inc.

Interventions Cesamet

Updated 6 times since 2017 Last updated: Nov 30, 2010 Started: Aug 31, 2006 Primary completion: Dec 31, 2007 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Enrollment was too slow

Other terminated trials from Bausch Health Americas, Inc.

More terminations from Bausch Health Americas, Inc.

Other Nausea and Vomiting trials with similar outcome

NCT00930332 · Phase PHASE1 · Jan 2012

Browse all Nausea and Vomiting trials

A PHASE4 clinical study on Nausea and Vomiting, this trial is terminated or withdrawn. The trial is conducted by Bausch Health Americas, Inc. and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2019 — Jan 2021 [monthly]

Terminated PHASE4
Jun 2018 — Jun 2019 [monthly]

Terminated PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bausch Health Americas, Inc.
Veeda Oncology

Data source: Veeda Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Columbus, United States